March 2017

We have written for years about the transition in health care from volume-based to value-based payment models. But the process has…

The 4th Due Diligence Summit for Life Sciences, taking place on May 18 and 19 of this year in Boston, Massachusetts at the Hyatt…

Part of President Obama’s landmark health care bill, the Affordable Care Act, imposed a federal tax on medical devices. That tax…

In late-February, we reported that CMS had recently finalized new Innovation Center models. However, now, in an interim rule, CMS…

Recently, as part of the course Legal Compliance Essentials for Drug, Device and Biotech Companies, Mitchell Hamline Law…

The United States Food and Drug Administration (FDA) offers a podcast series, known as the Director’s Corner, that features the…

National health expenditure is expected to grow an average of 5.6% annually from 2016 through 2025, according to a report…

The meaning of effectiveness of healthcare compliance programs has shifted in recent years. This article examines that…

Dr.Rafael Fonseca, a Chair of the Department of Medicine at the Mayo Clinic in Arizona and Distinguished Mayo Investigator,…

 Recently, as part of the course Legal Compliance Essentials for Drug, Device and Biotech Companies, Mitchell Hamline…